AR-13324 Ophthalmic Solution 0.02% BID

DRUG2 trials

Sponsors

Aerie Pharmaceuticals

Conditions

GlaucomaOcular HypertensionOpen-angle Glaucoma

Phase 3

Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension

CompletedNCT02207621

Aerie PharmaceuticalsOcular Hypertension, Open-angle Glaucoma

Start: 2014-07-31End: 2016-03-31Updated: 2018-04-06

Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

CompletedNCT02246764

Aerie PharmaceuticalsGlaucoma, Ocular Hypertension

Start: 2014-09-30End: 2016-12-31Updated: 2018-04-06